Found: 5
Select item for more details and to access through your institution.
Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e440, doi. 10.1093/cid/ciab912
- By:
- Publication type:
- Article
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 325, n. 7, p. 632, doi. 10.1001/jama.2021.0202
- By:
- Publication type:
- Article
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The Diagnostic and Prognostic Utility of Positron Emission Tomography! Computed Tomography-Based Follow-Up After Radiotherapy for Head and Neck Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 19, p. 4586, doi. 10.1002/cncr.24493
- By:
- Publication type:
- Article
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 5, p. 658, doi. 10.7326/M22-3428
- By:
- Publication type:
- Article